Skip to main content
Top
Published in: Archives of Women's Mental Health 6/2016

01-12-2016 | Original Article

Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder

Authors: Elgerta Ismaili, Sally Walsh, Patrick Michael Shaughn O’Brien, Torbjorn Bäckström, Candace Brown, Lorraine Dennerstein, Elias Eriksson, Ellen W. Freeman, Khaled M. K. Ismail, Nicholas Panay, Teri Pearlstein, Andrea Rapkin, Meir Steiner, John Studd, Inger Sundström-Paromma, Jean Endicott, C. Neill Epperson, Uriel Halbreich, Robert Reid, David Rubinow, Peter Schmidt, Kimberley Yonkers, Consensus Group of the International Society for Premenstrual Disorders

Published in: Archives of Women's Mental Health | Issue 6/2016

Login to get access

Abstract

Whilst professional bodies such as the Royal College and the American College of Obstetricians and Gynecologists have well-established standards for audit of management for most gynaecology disorders, such standards for premenstrual disorders (PMDs) have yet to be developed. The International Society of Premenstrual Disorders (ISPMD) has already published three consensus papers on PMDs covering areas that include definition, classification/quantification, clinical trial design and management (American College Obstetricians and Gynecologists 2011; Brown et al. in Cochrane Database Syst Rev 2:CD001396, 2009; Dickerson et al. in Am Fam Physician 67(8):1743–1752, 2003). In this fourth consensus of ISPMD, we aim to create a set of auditable standards for the clinical management of PMDs. All members of the original ISPMD consensus group were invited to submit one or more auditable standards to be eligible in the inclusion of the consensus. Ninety-five percent of members (18/19) responded with at least one auditable standard. A total of 66 auditable standards were received, which were returned to all group members who then ranked the standards in order of priority, before the results were collated. Proposed standards related to the diagnosis of PMDs identified the importance of obtaining an accurate history, that a symptom diary should be kept for 2 months prior to diagnosis and that symptom reporting demonstrates symptoms in the premenstrual phase of the menstrual cycle and relieved by menstruation. Regarding treatment, the most important standards were the use of selective serotonin reuptake inhibitors (SSRIs) as a first line treatment, an evidence-based approach to treatment and that SSRI side effects are properly explained to patients. A set of comprehensive standards to be used in the diagnosis and treatment of PMD has been established, for which PMD management can be audited against for standardised and improved care.
Literature
go back to reference Borenstein JE, Dean BB, Yonkers KA, Endicott (2007) Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. Obstet Gynecol 109:1068–75CrossRefPubMed Borenstein JE, Dean BB, Yonkers KA, Endicott (2007) Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. Obstet Gynecol 109:1068–75CrossRefPubMed
go back to reference Brown J, O’Brien PMS, Marjoribanks J, Wyatt K (2009) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2:CD001396 Brown J, O’Brien PMS, Marjoribanks J, Wyatt K (2009) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2:CD001396
go back to reference Dickerson L, Mazuck P, Hunter M (2003) Premenstrual syndrome. Am Fam Physician 67(8):1743–1752PubMed Dickerson L, Mazuck P, Hunter M (2003) Premenstrual syndrome. Am Fam Physician 67(8):1743–1752PubMed
go back to reference Dimmock PW, Wyatt KM, Jones PW, O’Brien PM (2000) Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome; a systematic review. Lancet 356:1131–1136CrossRefPubMed Dimmock PW, Wyatt KM, Jones PW, O’Brien PM (2000) Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome; a systematic review. Lancet 356:1131–1136CrossRefPubMed
go back to reference Ismail K, Nevatte T, O’Brien PMS, Paschetta E, Bäckström T (2013) Clinical subtypes of core premenstrual disorders: a Delphi survey. Arch Womens Ment Health 16:197–201CrossRefPubMed Ismail K, Nevatte T, O’Brien PMS, Paschetta E, Bäckström T (2013) Clinical subtypes of core premenstrual disorders: a Delphi survey. Arch Womens Ment Health 16:197–201CrossRefPubMed
go back to reference Kadian S, O’Brien S (2012) Classification of premenstrual disorders as proposed by the International Society for Premenstrual Disorders. Menopause Int 18:43–7PubMed Kadian S, O’Brien S (2012) Classification of premenstrual disorders as proposed by the International Society for Premenstrual Disorders. Menopause Int 18:43–7PubMed
go back to reference Lopez LM, Kaptein AA, Helmerhorst FM (2012) Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev (Issue 2). Art. No.: CD006586 Lopez LM, Kaptein AA, Helmerhorst FM (2012) Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev (Issue 2). Art. No.: CD006586
go back to reference Nevatte T, O’Brien PMS, Backstrom T, Brown C et al (2013) ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health 16:279–291 Nevatte T, O’Brien PMS, Backstrom T, Brown C et al (2013) ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health 16:279–291
go back to reference O’Brien PMS, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN et al (2011) Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 14:13–21CrossRefPubMedPubMedCentral O’Brien PMS, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN et al (2011) Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 14:13–21CrossRefPubMedPubMedCentral
go back to reference Panay N (2009) Management of premenstrual syndrome. Br Med J 35(3):187–194 Panay N (2009) Management of premenstrual syndrome. Br Med J 35(3):187–194
go back to reference Rapkin AJ, Kuo J (2007) Neurotransmitter physiology: the basics for understanding premenstrual syndrome. In: O’Brien PMS, Rapkin A, Schmidt P (eds) The premenstrual syndromes: PMS and PMDD. Informa Healthcare, London, pp 69–71 Rapkin AJ, Kuo J (2007) Neurotransmitter physiology: the basics for understanding premenstrual syndrome. In: O’Brien PMS, Rapkin A, Schmidt P (eds) The premenstrual syndromes: PMS and PMDD. Informa Healthcare, London, pp 69–71
go back to reference Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borensstein J (2008) Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 111:1175–1182CrossRefPubMedPubMedCentral Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borensstein J (2008) Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol 111:1175–1182CrossRefPubMedPubMedCentral
go back to reference Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM (2004) The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta-analysis. BJOG 111:585–593CrossRefPubMed Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM (2004) The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta-analysis. BJOG 111:585–593CrossRefPubMed
go back to reference Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A (2005) Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 106:492–501CrossRefPubMed Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A (2005) Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 106:492–501CrossRefPubMed
go back to reference Yonkers K, O’Brien PMS, Eriksson E (2008) Premenstrual syndrome. PubMed 10:1200–1210 Yonkers K, O’Brien PMS, Eriksson E (2008) Premenstrual syndrome. PubMed 10:1200–1210
Metadata
Title
Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder
Authors
Elgerta Ismaili
Sally Walsh
Patrick Michael Shaughn O’Brien
Torbjorn Bäckström
Candace Brown
Lorraine Dennerstein
Elias Eriksson
Ellen W. Freeman
Khaled M. K. Ismail
Nicholas Panay
Teri Pearlstein
Andrea Rapkin
Meir Steiner
John Studd
Inger Sundström-Paromma
Jean Endicott
C. Neill Epperson
Uriel Halbreich
Robert Reid
David Rubinow
Peter Schmidt
Kimberley Yonkers
Consensus Group of the International Society for Premenstrual Disorders
Publication date
01-12-2016
Publisher
Springer Vienna
Published in
Archives of Women's Mental Health / Issue 6/2016
Print ISSN: 1434-1816
Electronic ISSN: 1435-1102
DOI
https://doi.org/10.1007/s00737-016-0631-7

Other articles of this Issue 6/2016

Archives of Women's Mental Health 6/2016 Go to the issue